Source: http://health.yahoo.net/news/s/nm/eu-body-backs-novartis-galvus-eucreas-for-diabetes-indications
Sunday, 23 September 2012
EU body backs Novartis' Galvus, Eucreas for diabetes indications
ZURICH (Reuters) - European regulators on Friday issued positive opinions for new indications of Novartis AG drugs Galvus and Eucreas in combination with other treatments for type 2 diabetes patients. The Committee for Medicinal Products for Human...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.